The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
3-(5-Methylbenzo[d]oxazol-2-yl)-2-(N-3-diethylaminopropyl)aminoquinoxaline ID: ALA4570396
PubChem CID: 155562446
Max Phase: Preclinical
Molecular Formula: C23H27N5O
Molecular Weight: 389.50
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: CCN(CC)CCCNc1nc2ccccc2nc1-c1nc2cc(C)ccc2o1
Standard InChI: InChI=1S/C23H27N5O/c1-4-28(5-2)14-8-13-24-22-21(25-17-9-6-7-10-18(17)26-22)23-27-19-15-16(3)11-12-20(19)29-23/h6-7,9-12,15H,4-5,8,13-14H2,1-3H3,(H,24,26)
Standard InChI Key: VGXNMESKOMMZKQ-UHFFFAOYSA-N
Molfile:
RDKit 2D
29 32 0 0 0 0 0 0 0 0999 V2000
1.4514 -3.5948 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4502 -4.4143 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1583 -4.8233 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1565 -3.1859 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8651 -3.5912 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8659 -4.4102 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5744 -4.8173 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.2827 -4.4064 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2779 -3.5843 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5688 -3.1809 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.9831 -3.1714 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9919 -4.8123 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.6981 -4.4009 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7290 -3.5010 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.0609 -2.3600 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.8592 -2.1851 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2694 -2.8883 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0817 -2.8837 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4847 -2.1765 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0694 -1.4726 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2585 -1.4807 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4074 -4.8068 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1135 -4.3954 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8228 -4.8013 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.5289 -4.3899 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8259 -5.6185 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2382 -4.7958 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5352 -6.0243 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3019 -2.1704 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 5 1 0
9 11 1 0
8 12 1 0
12 13 1 0
11 14 2 0
14 17 1 0
16 15 1 0
15 11 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 16 1 0
13 22 1 0
22 23 1 0
23 24 1 0
24 25 1 0
24 26 1 0
25 27 1 0
26 28 1 0
19 29 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 389.50Molecular Weight (Monoisotopic): 389.2216AlogP: 4.89#Rotatable Bonds: 8Polar Surface Area: 67.08Molecular Species: BASEHBA: 6HBD: 1#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 9.94CX LogP: 4.43CX LogD: 1.93Aromatic Rings: 4Heavy Atoms: 29QED Weighted: 0.43Np Likeness Score: -1.35
References 1. Liu QQ, Lu K, Zhu HM, Kong SL, Yuan JM, Zhang GH, Chen NY, Gu CX, Pan CX, Mo DL, Su GF.. (2019) Identification of 3-(benzazol-2-yl)quinoxaline derivatives as potent anticancer compounds: Privileged structure-based design, synthesis, and bioactive evaluation in vitro and in vivo., 165 [PMID:30685528 ] [10.1016/j.ejmech.2019.01.004 ]